Sec. Individual and Social Behaviors
Volume 8 - 2014 | https://doi.org/10.3389/fnbeh.2014.00132
Intrinsic properties and neuropharmacology of midline paraventricular thalamic nucleus neurons
- Neuroscience Program and Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada
Neurons in the midline and intralaminar thalamic nuclei are components of an interconnected brainstem, limbic and prefrontal cortex neural network that is engaged during arousal, vigilance, motivated and addictive behaviors, and stress. To better understand the cellular mechanisms underlying these functions, here we review some of the recently characterized electrophysiological and neuropharmacological properties of neurons in the paraventricular thalamic nucleus (PVT), derived from whole cell patch clamp recordings in acute rat brain slice preparations. PVT neurons display firing patterns and ionic conductances (IT and IH) that exhibit significant diurnal change. Their resting membrane potential (RMP) is maintained by various ionic conductances that include inward rectifier (Kir), hyperpolarization-activated nonselective cation (HCN) and TWIK-related acid sensitive (TASK) K+ channels. Firing patterns are regulated by high voltage-activated (HVA) and low voltage-activated (LVA) Ca2+ conductances. Moreover, transient receptor potential (TRP)-like nonselective cation channels together with Ca2+- and Na+-activated K+ conductances (KCa; KNa) contribute to unique slow afterhyperpolarizing potentials (sAHPs) that are generally not detectable in lateral thalamic or reticular thalamic nucleus neurons. The excitability of PVT neurons is also modulated by activation of neurotransmitter receptors associated with afferent pathways to PVT and other thalamic midline nuclei. We report on receptor-mediated actions of GABA, glutamate, monoamines and several neuropeptides: arginine vasopressin, gastrin-releasing peptide, thyrotropin releasing hormone and the orexins (hypocretins). This review represents an initial survey of intrinsic and transmitter-sensitive ionic conductances that are deemed to be unique to this population of midline thalamic neurons, information that is fundamental to an appreciation of the role these thalamic neurons may play in normal central nervous system (CNS) physiology and in CNS disorders that involve the dorsomedial thalamus.
The thalamus, the principal gateway for information from various sensory modalities to reach higher cognitive centers, is a critical component of conscious behavior. The midline and intralaminar nuclei, initially regarded as relays in a “nonspecific” thalamocortical arousing system, have now gained recognition not only for their specific two way connectivity with areas of cortex and striatum, but also for their involvement in a variety of distinct functions, notably vigilance and arousal, nociception, stress, memory and cognition, and motivated behaviors (Groenewegen and Berendse, 1994; Bhatnagar et al., 2002; Van der Werf et al., 2002; Sewards and Sewards, 2003). In addition, there is evidence that dysfunction of this region of thalamus may contribute to and/or cause various psychopathologies, sleep disorders and limbic epilepsy (see reviews by Benarroch, 2008; Rajasekaran et al., 2009; Price and Drevets, 2010). Knowledge of the intrinsic and synaptic properties that regulate the excitability of neurons is fundamental to understanding neural communication, integration and information processing in the central nervous system (CNS). To date, interest in thalamic function at the cellular level has largely focused on the role of neurons in specific relay and reticular nuclei, whereas comparatively little research has been devoted to the cellular physiology and function of neurons constituting the midline and intralaminar thalamic nuclei. As a contribution towards this objective we focus this review on the electrophysiology and pharmacology of neurons in paraventricular thalamic nucleus (PVT), a stable midline structure throughout mammalian evolution. In the rat, PVT extends rostrocaudally below the third ventricle and is the most dorsal component of the thalamic midline-intralaminar nuclear complex. In both rodents and primates (monkey), PVT neurons have extensive connectivity with a variety of neurons in the hypothalamus, brainstem, limbic regions (bed nucleus of stria terminalis, nucleus accumbens, amygdala) and prefrontal cortex (Berendse and Groenewegen, 1990; Su and Bentivoglio, 1990; Moga et al., 1995; Otake and Ruggerio, 1995; Kawano et al., 2001; Peng and Bentivoglio, 2004; Li and Kirouac, 2008, 2012; Vertes and Hoover, 2008; Hsu and Price, 2009). The observation that PVT neurons exhibit enhanced immediate early gene (e.g., c-Fos) expression during arousal and after exposure to various stressors (e.g., restricted mobility, food deprivation) and psychostimulants (reviewed in Price and Drevets, 2010) suggests that these neurons participate in a variety of behaviors. PVT also appears as a common nodal structure in central pathways integrating salt appetite, energy balance and food reward (Kelley et al., 2005; Parsons et al., 2006; Shekhtman et al., 2007; Kampe et al., 2009). Collectively, these findings implicate an involvement of this midline cell group in survival-oriented behaviors, homeostasis and possibly addictions.
PVT neurons have somata with diameters in the 12–20 micron range and 3–7 aspiny main dendrites that extend for several hundred microns (Richter et al., 2006; Zhang et al., 2009, 2010), and synthesize glutamate for rapid neurotransmission (Christie et al., 1987; Csáki et al., 2000; Hur and Zaborszky, 2005). Whereas PVT has been assigned anterior and posterior components based on functional considerations (e.g., see Bhatnagar et al., 2002) and differing anatomical connectivity (e.g., Li and Kirouac, 2012), the morphology of PVT neurons based on intracellular labeling reveals relatively small variations along the rostrocaudal axis of the nucleus (Brunton and Charpak, 1998; Heilbronner and Flügge, 2005). Information presented here on their intrinsic electrical properties and synaptic pharmacology is derived from observations obtained with patch-clamp recording techniques in rat brain slice preparations. In most earlier reports, data were acquired from slices prepared during the animal’s resting period, e.g., at zeitgeber (ZT) 4–10, (ZT 0 is light on; animals maintained on a 12 h light/12 h dark cycle). However, PVT neurons are known to receive an innervation from the suprachiasmatic nucleus (Peng and Bentivoglio, 2004; also see below) which contains the master circadian pacemaker (Reppert and Weaver, 2001), and to express diurnal changes in early gene expression (Peng et al., 1995; Novak and Nunez, 1998). These features, together with the fact that rats are nocturnal feeders prompted a comparison of intrinsic properties in neurons recorded in slices prepared during ZT 2–6 (day period) with those in slices prepared during ZT 14–18 (night period), when animals are active (Kolaj et al., 2012). Where data are available, these comparisons are considered in the following review.
Membrane Properties and Activity Patterns
Compared with neurons in day period slices, neurons in night period slices have a mean resting membrane potential (RMP) that is ∼10 mV more depolarized and have a significantly lower membrane conductance (Figure 1). A comparison of the mean current-voltage relationship of neurons from day period and night period slices revealed a differential membrane current with a reversal potential near the K+ equilibrium potential, implying that one or more K+ conductances are contributing to the observed difference in membrane potential (MP; Kolaj et al., 2012). In addition, both cell attached and whole cell recordings reveal that most PVT neurons in day period slices are silent, contrasting with neurons in night period slices where the majority of PVT neurons display tonic or burst firing (Figure 1).
Figure 1. PVT neurons express diurnal changes. A schematic illustrating the differences in intrinsic electrical properties of PVT neurons recorded in slices from different ZT periods. In night period slices, neurons have a more depolarized resting membrane potential (RMP), lower resting membrane conductance, in part owing to lower overall K+ currents (IK), and larger amplitude T-type Ca2+ (IT) and hyperpolarization-activated cation (IH) currents. These changes result in increased spontaneous tonic and burst firing, and enhanced recurrent activity subsequent to generation of a low-threshold spike (LTS). For details, see Kolaj et al. (2012).
Low-Threshold Ca2+ Spike, T-Type Ca2+ Channels and IT
Similar to thalamocortical and reticular thalamic neurons, PVT neurons exhibit two modes of activity, tonic and burst firing (reviewed in McCormick and Bal, 1997). Thus, a step depolarization from RMP initiates tonic firing with varying degrees of spike frequency adaptation, whereas a step depolarization from a more hyperpolarized MP or the offset of a step hyperpolarization from RMP triggers a low-threshold Ca2+ spike, or LTS (Figure 1, single LTS). The LTS is often sufficient to elicit a burst of tetrodotoxin (TTX)-sensitive Na+ action potentials, and may be followed by a slow afterhyperpolarization (sAHP) and a series of oscillatory bursts (Figure 1, recurrent LTS). The LTS results from activation of low voltage-activated (LVA) T-type Ca2+ channels, which are major contributors to rhythmic oscillatory behavior in thalamic and other neurons (reviewed in Perez-Reyes, 2003) and can be blocked by nickel (Ni2+) (Huguenard, 1996). In PVT neurons, Ni2+ can be seen to completely arrest spontaneous bursting or LTS-induced recurring bursting activity, whereas cadmium (Cd2+) has no influence on these activities (Zhang et al., 2009), observations implying that HVA Ca2+ channels have little or no contribution to bursting behavior in PVT neurons, although they are important for tonic firing (see Wong et al., 2013).
The mammalian genome encodes genes for 3 distinct isoforms of the T-type Ca2+ channel, Cav3.1 (or α1G), Cav3.2 (or α1H), and Cav3.3 (or α1I) (reviewed in Perez-Reyes, 2003). Our RT-PCR analysis in rat brain revealed that the major subunit in PVT is Cav3.1, with fewer Cav3.3 and almost no Cav3.2 (Kolaj et al., 2012). This is consistent with earlier investigations reporting that the Cav3.1 subtype is most dominant in midline thalamus in rat (Talley et al., 1999; McKay et al., 2006). However, a recent study in mice featuring the importance of the Cav3.2 subtype in hyperalgesia (Chen et al., 2010) suggests a possible variation in subtypes between rodent species.
A further evaluation of properties of LVA Ca2+ channels with confocal microscopy and Ca2+ imaging techniques reveals features that may be unique to LVA T-type Ca2+ channels in PVT neurons. First, LVA Ca2+ channels are strongly represented in both somata and dendrites, but the magnitude of LVA Ca2+ channel-evoked Ca2+ transients is significantly greater in proximal dendrites (up to 20 µm from the soma) than in somata. Also, these Ca2+ channels display considerable heterogeneity in their distribution (or lack thereof) within different dendrites (see Richter et al., 2006). Second, Ca2+ entry via LVA Ca2+ channels is coupled to Ca2+-induced Ca2+ release (CICR) from intracellular Ca2+ stores, a phenomenon not apparent in reticular thalamic nucleus or ventrolateral thalamocortical relay neurons (Figures 2A–C; see Richter et al., 2005). It is anticipated that further investigations will reveal a link between CICR and the slow afterpotentials (Figures 2D–G; see below) that also appear to be uniquely featured in midline thalamic neurons.
Figure 2. PVT neurons express unique T-type Ca2+ channel-mediated intracellular calcium profiles, and sAHPs. (A) On the left, a typical Ca2+ response profile in a single PVT neuron displays a fast and a slow phase of the Ca2+ signal in response to a single voltage pulse that activates T-type Ca2+ channels. On the right, average trace from 12 neurons that exhibit Ca2+ response profiles consistent with calcium-induced calcium release (CICR) in response to repetitive activation of T-type Ca2+ channels. (B) For contrast, trace from a single nRT neuron (left) exhibits no slow Ca2+ response and average trace from 13 neurons (right) shows no evidence of CICR. For details, see Richter et al. (2005). (C) Distribution of thalamic neurons that did (blue circles) or did not (gray circles) exhibit CICR in response to repetitive activation of T-type Ca2+ channels. Abbreviations and scheme are based on the rat atlas by Paxinos and Watson (1998) (Reproduced in part with permission from Richter et al., 2005). (D) Voltage traces from the same PVT neuron illustrate a spike train-induced (left) and an LTS-induced (right) sAHP (shaded areas). (E, F) Using similar protocols, representative traces indicate that similar sAHPs are not observed in ventrobasal (VB; black trace and symbols) or reticular thalamic (nRT; gray trace and symbols) neurons. (G) Distribution of tested neurons to depict that only cells in midline and intralaminar thalamus displayed sAHPs (red circles). Abbreviations and scheme are based on the rat atlas by Paxinos and Watson (1998) (Reproduced in part with permission from Zhang et al., 2010).
IT: day period vs. night period
The increase in burst firing activity observed in PVT neurons in night period slices (Figure 1) coincides with an increase in IT amplitude at MPs more depolarized than −60 mV (Kolaj et al., 2012). Although an underlying mechanism remains to be identified, RT-PCR analysis in tissue samples from anterior PVT reveals a significant increase in mRNA for both Cav3.1 and Cav3.3 isoforms in night period slices (Kolaj et al., 2012). In thalamocortical and reticular thalamic neurons, an increased “window” component of IT originating from the region of overlap between steady-state activation and inactivation curves of IT has been proposed to contribute to slow rhythmic burst firing (Crunelli et al., 2005; Blethyn et al., 2006). Thus a “window” IT that is increased in PVT neurons in night period slices could permit amplification of bursting behavior at more depolarized RMPs.
Hyperpolarization-Activated Nonselective Cation Channels (HCN) and IH
The majority of PVT neurons display a depolarizing voltage sag during a sustained membrane hyperpolarization and a slow inward current relaxation in response to a hyperpolarizing voltage step (see Figure 2 in Zhang et al., 2006b), features consistent with a membrane current (IH) resulting from activation of HCN channels (reviewed in Biel et al., 2009). In thalamocortical neurons, HCN channels contribute to both RMPs and to oscillatory and bursting activity (e.g., McCormick and Pape, 1990). Consistent with a similar role in PVT neurons is the observation of a gradual membrane hyperpolarization and cessation of spontaneous oscillatory behavior following bath application of ZD7288, a selective inhibitor of HCN channels (see Figure 4A in Kolaj et al., 2012). HCN channels are composed of four members, HCN 1–4, with a wide CNS expression (Monteggia et al., 2000; Notomi and Shigemoto, 2004; Biel et al., 2009). A recent RT-PCR analysis indicates that the major subunit in midline thalamus is HCN2 followed by HCN4 > HCN3 > HCN1 (Kolaj et al., 2012).
IH: day period vs. night period
A comparison of the effect of ZD7288 on neurons maintained at similar MPs (−60 mV) revealed a significantly larger hyperpolarization in neurons from night period slices compared to neurons from day period slices (Kolaj et al., 2012). A voltage clamp assessment of IH indicated an increase in IH in neurons from night period slices, starting at holding potentials more hyperpolarized than −80 mV (Kolaj et al., 2012). However, RT-PCR assessment of mRNA expression of individual HCN channel isoforms in punch biopsies from the anterior PVT area revealed no significant difference between day and night period slices (Kolaj et al., 2012), suggesting that diurnal changes in IH result from a mechanism that is different from that underlying changes in IT.
Enhanced Spontaneous and Induced Firing Patterns in Night Period Slices
In thalamic neurons, burst and tonic firing patterns are closely related to MPs, and the data reviewed here indicate a decrease in resting K+ conductance as well as an increase in T-type Ca2+ and HCN-type of conductances in PVT neurons in night period slices (Figure 1). These changes influence spontaneous and induced firing behaviors. As reported in Kolaj et al. (2012), no marked differences exist in the response of neurons from day vs. night period slices to step changes in MP to −50 mV, where most neurons display tonic firing. However, upon a −10 mV change in MP to −60 mV, most neurons in day period slices became silent while most neurons from night period slices exhibited LTS-induced burst firing. In addition, upon return of MP to ~ −60 mV following a step hyperpolarization of sufficient duration, most PVT neurons in day period slices responded with a single LTS, while a similar protocol applied to PVT neurons in night period slices triggered recurring LTS-initiated bursts (Figure 1).
Inward Rectifier K+ Channels (Kir)
Current-voltage relationships in PVT neurons typically demonstrate a strong time independent inward rectification (see Figure 2 in Zhang et al., 2006b), a feature indicative of inward rectifier K+ channels, or Kir (Hibino et al., 2010). Three Kir channel subfamilies are proposed to regulate neuronal excitability: Kir2 forms open or constitutively active inward rectifier K+ channels; Kir3 forms G protein-coupled inward rectifier K+ channels (GIRK) that are usually closed but in certain conditions can be open due to tonic activation by a Gi/Go protein-coupled receptor; Kir6 forms ATP-sensitive inward rectifier K+ channels in complexes with sulfonylurea receptors and are open when ATP levels are low (Stanfield et al., 2002; Hibino et al., 2010). All three Kir subfamilies are expressed in midline thalamus (Prüss et al., 2005; Thomzig et al., 2005; Saenz del Burgo et al., 2008). Recent observations using specific ion channel blockers suggest that all Kir channels are not only present in PVT neurons but also contribute to maintaining their RMPs (Hermes et al., 2013; Zhang et al., 2013). These findings are of particular interest since they indicate a role for GIRK channels in maintaining RMPs, a function previously detected in medial prefrontal cortex pyramidal (Witkowski et al., 2008) and locus ceruleus neurons (Torrecilla et al., 2002), but novel for thalamus.
Resting K+ conductances are major contributors to neuronal RMPs, and their inhibition by neurotransmitters represents a key mechanism to modulate cell excitability (McCormick, 1992). Several members of the K+ two-pore-domain (K2P) channels are constitutively active at rest and exhibit properties expected of background “leak” channels (Goldstein et al., 2001; Patel and Honoré, 2001). Two of these, TWIK-related acid-sensitive K+ channel 1 (TASK-1) and TASK-3 channels, contribute substantially to the background membrane current in thalamocortical neurons (Meuth et al., 2006). TASK-1 and TASK-3 transcripts are also expressed in midline and intralaminar regions of thalamus (e.g., Talley et al., 2001) and observations in PVT neurons (Doroshenko and Renaud, 2009) also indicate the expression of a functional background pH-sensitive conductance with properties consistent with TASK-like channels. Briefly, PVT neurons demonstrate large shifts in RMP or membrane current (under voltage-clamp) in response to lowering or raising extracellular pH. These are due largely to changes in one or more K+ conductances that are reduced in acidic (pH 6.3) and enhanced in alkaline (pH 8.3) media. In addition, exposure to the local anesthetic bupivacaine or the endocannabinoid anandamide mimics the effects of acidic media by reducing K+ conductance, whereas exposure to the volatile anesthetic isoflurane induces membrane hyperpolarization by enhancing a K+ conductance (Maingret et al., 2001; Meuth et al., 2006; Veale et al., 2007).
Slow Afterhyperpolarizations (sAHPs)
The influx of Ca2+ ions through either HVA or LVA Ca2+ channels can have a variety of consequences, including the activation of different K+ conductances that contribute to membrane afterhyperpolarizations, or AHPs. AHPs provide neurons with an important intrinsic means of controlling their excitability and activity patterns over variable segments of time. AHPs are typically subdivided into three phases, fast (fAHP), medium (mAHP) and slow (sAHP), with different Ca2+-activated K+ channels (KCa) contributing to each phase (Faber and Sah, 2003; Vogalis et al., 2003). PVT and other midline thalamic neurons express two prominent apamin-resistant sAHPs: a spike train-induced sAHP, and an LTS-induced sAHP (Figure 2D). Interestingly, neither sAHP appears to exist in neurons sampled in several other regions of thalamus (Figures 2E–G).
The spike train-induced sAHP in PVT neurons is abolished in the presence of TTX, suggesting that action potential-associated Ca2+ influx through HVA Ca2+ channels triggers sIAHP, the underlying current. An analysis of this sIAHP (Zhang et al., 2010) identified the following characteristics: a dependency on Ca2+ influx; a contribution from each of the known HVA Ca2+ channel subtypes; a lack of sensitivity to known blockers of KCa channels; a significant reduction in the presence of a novel selective sAHP blocker UCL-2077 (Shah et al., 2006) and the nonselective K+ channel blockers barium and tetraethylammonium (TEA). In addition, blockade of HVA Ca2+ channels revealed an activity-dependent, Ca2+-independent component of the sAHP (see Figure 6 in Zhang et al., 2010) that exhibited the following properties: sensitivity to changes in [K+]o; insensitivity to changes in [Cl−]i; blockade by substitution of Na+ with Li+; sensitivity to quinidine (Zhang et al., 2010). These features are a hallmark of KNa channels encoded by members of the Slo gene family, Slo2.1 (Slick) and Slo2.2 (Slack) that have a wide expression in brain, including PVT (Bhattacharjee et al., 2002, 2005; Bhattacharjee and Kaczmarek, 2005). Taken together, the data suggest that PVT neurons possess KCa channels that are principal contributors to the spike train-induced sAHPs at the lower end of the activity-dependent scale, together with KNa channels that become progressively more engaged under conditions associated with more intense firing, as might occur during rhythmic bursting (Zhang et al., 2010).
The LTS-induced sAHP exhibits the following properties: long duration; an amplitude that is independent of the number of action potentials triggered by the LTS; resistance to TTX; dependence on Ca2+ influx and blockade by Ni2+; sensitivity to [K+]o; reduction by nonselective K+ channel blockers barium and TEA; insensitivity to specific KCa channel blockers (Zhang et al., 2009). In addition, in contrast to the spike train induced sAHPs, the LTS-induced sAHP lacks sensitivity to UCL-2077, suggesting involvement of different type(s) of K+ channel(s).
The observed prevalence of sAHPs in midline thalamus raises the notion that neurons in this part of thalamus are endowed with unique types of K+ channels. Functionally, the sAHP may be an important intrinsic mechanism governing typical rhythmic activities within this region of thalamus, and a possible target for neurotransmitter receptors (Zhang et al., 2009, 2010; see Orexins below, and Figure 3). Another functional consequence of large sAHPs is a propensity for spike frequency adaptation, a feature that exhibits variable expression in PVT neurons (Zhang et al., 2010).
Figure 3. Some potential consequences of glutamate and orexin co-release at a synapse in PVT. On the left, microphotograph of coronal section from rat brain (bregma ∼ −3.14) reveal a dense distribution of orexin A-immunoreactive fibers in PVT nucleus. Abbreviations: D3v, dorsal 3rd ventricle; MHb, medial habenula. On the right, schematic synapse depicting action potential invasion of an axon terminal in PVT containing storage vesicles for a rapid transmitter (glutamate, red symbols) and a neuropeptide (orexin A or B, green symbols). Presynaptically released glutamate diffuses across the synaptic cleft to act at postsynaptic ionotropic AMPA and NMDA receptors, promoting cation influx and induction of rapid excitatory postsynaptic currents. In addition, glutamate release may potentially activate metabotropic group II (mGluR-II) receptors to open pre- and/or postsynaptic K+ channels (Hermes and Renaud, 2011). Activity-dependent co-release of orexins and activation of metabotropic orexin receptors (orexinR1/2) may have several postsynaptic actions that collectively result in enhanced neuronal excitability by: (a) opening of nonselective cation channels (NSCC; Kolaj et al., 2007); (b) closing of K+ channels, including two-pore-domain TASK-like channels that are constitutively active at rest (Doroshenko and Renaud, 2009); and (c) suppression of KCa and KNa channels underlying spike train induced sAHPs (Zhang et al., 2010).
γ-aminobutyric acid (GABA)
GABA is the dominant inhibitory neurotransmitter in the forebrain, regulating cell excitability via rapidly acting anion-permeable ionotropic GABAA receptors (GABAARs) and slowly acting, K+-permeable, G protein-coupled metabotropic GABAB receptors (GABABRs). In the mammalian thalamus, GABAergic local circuit neurons have a differential and selective distribution in different species. In primates and carnivores, they are abundant in most of the dorsal thalamic nuclei. However, in rodents, they are found sparingly in intralaminar nuclei and are virtually absent in midline nuclei, including PVT (Arcelli et al., 1997). Nonetheless, the neuropil in rodent midline nuclei displays a high density of GABA-immunoreactive fibers and terminal boutons (Ottersen and Storm-Mathisen, 1984). In PVT, a portion of this input likely originates in the hypothalamic suprachiasmatic nuclei (SCN; Peng and Bentivoglio, 2004) where the majority of neurons express the GABA synthesizing enzyme glutamic acid decarboxylase (GAD; Moore and Speh, 1993; Kawano et al., 2001). Another potential source of GABAergic input to PVT originates from subpopulations of GAD-expressing arcuate nucleus neurons that co-express POMC or its posttranslational product β-endorphin (Bloom et al., 1978; Wittmann et al., 2013) or agouti-related protein (AgRP; Horvath et al., 1997; Cansell et al., 2012; Betley et al., 2013). The following pertains to GABA’s actions and potential roles in PVT.
Ionotropic GABAARs are composed of a combination of subunits (i.e., αβγδεθρ) that dictate the cellular distribution, physiological properties and pharmacology of the receptor. In ventrobasal (VB) thalamic nucleus neurons, synaptically located α1β2γ2-containing receptors mediate the “phasic” postsynaptic form of GABAergic inhibition, via receptors permeable to Cl− and to a lesser extent (Farrant and Nusser, 2005). While details of GABAAR subunit composition remain to be defined in PVT neurons, these neurons clearly display “phasic” inhibition in the form of evoked, spontaneous, or miniature inhibitory postsynaptic currents (eIPSCs, sIPSCs, mIPSCs). An example is found in the analysis of the SCN innervation to anterior PVT (Zhang et al., 2006b). In brain slice preparations that maintain the integrity of the SCN innervation to PVT, electrical stimulation in SCN can evoke IPSCs that display a reversal potential around −70 mV, close to the calculated chloride ion equilibrium potential (~ −66 mV at 22°C) for this preparation (Zhang et al., 2006b). Such phasic IPSCs are reversibly suppressed by the GABAAR antagonists bicuculline and SR95531, and also by the GABAAR channel blocker picrotoxin. Many VB thalamic nucleus neurons also display extrasynaptic GABAARs that contain α4 and/or δ subunits which are known to mediate a “tonic” form of inhibition, initiated by ambient levels of extracellular GABA that escape presynaptic reuptake (Glykys and Mody, 2007; Belelli et al., 2009). Tonic GABAARs are “ON” all the time, and their sensitivity to neurosteroids, general anesthetics and alcohol make them potential therapeutic targets (Brinkley and Mody, 2012). While tonic GABAARs have not yet received detailed investigation in midline thalamus, a trademark of their presence in PVT neurons would be the detection of a steady outward membrane current in Cl−-loaded cells upon application of SR95531.
Metabotropic GABABRs operate via Gαi/o-type G proteins to regulate cell excitability through both postsynaptic and presynaptic modulation of K+ ion channels (Gassmann and Bettler, 2012). GABABRs are prominently expressed in the midline thalamus (Margeta-Mitrovic et al., 1999), yet there is little information on their neuropharmacology.
The available data imply that GABAARs and GABABRs are likely to have a role in the neurophysiology (and possibly neuropathology) in midline thalamus. In rodents, agonists targeting GABARs specifically in PVT induce major changes in behavior, including induction of feeding (Stratford and Wirtshafer, 2013) and abolition of cocaine-conditioned place preference (Browning et al., 2014). Studies in a rat model of chronic temporal lobe epilepsy (limbic epilepsy) reveal significant changes in eIPSCs and GABAAR subunit expression in PVT (Rajasekaran et al., 2009). One might speculate that changes in GABARs contribute to the exceptional sensitivity (i.e., c-Fos expression) of PVT neurons to various stressors. Interestingly, in rodents subjected to an acute behavioral stress, an evaluation of neurons in the hypothalamic parvicellular paraventricular nucleus reveals changes in their postsynaptic chloride ion gradients, rendering GABAAR signaling excitatory rather than inhibitory (Hewitt et al., 2009). Future investigations need to consider whether impairment in synaptic (phasic) or extrasynaptic (tonic) GABAR-mediated inhibition contributes to various CNS disorders where midline thalamus may be involved (see Brinkley and Mody, 2012). GABABR ligands have already shown potential therapeutic value in various neurological (epilepsy) and neuropsychiatric disorders (e.g., schizophrenia and addictions; Bettler et al., 2004).
Glutamate is recognized as the dominant CNS excitatory neurotransmitter interacting with ionotropic (AMPA, kainate (KA) and NMDA) receptors to mediate rapid excitatory transmission, and with G protein-coupled metabotropic glutamate receptors (mGluRs) to mediate slow excitatory or inhibitory actions (reviewed in Salt and Eaton, 1996). Both types of receptors are present in midline thalamus and PVT neurons exhibit properties consistent with actions mediated by both types of glutamate receptors (see below). Glutamatergic neurons can be identified by their co-expression of vesicular glutamate transporters (VGLUTs), considered definitive markers for neurons and axon terminals that synthesize and/or release glutamate (e.g., Fremeau et al., 2004). PVT neurons express VGLUT2 (Hur and Zaborszky, 2005) and (should they have local axon collaterals) may be an intranuclear source of glutamatergic input. VGLUTs serve to identify many sources of glutamatergic innervation to PVT, including: brainstem neurons containing markers for monamines and neuropeptides (Mestikawy et al., 2011; Schöne and Burdakov, 2012); lateral hypothalamic orexin/hypocretin neurons (Torrealba et al., 2003; Henny et al., 2010), recently shown with optogenetic probes to evoke typical rapid glutamatergic responses in neurons targeted by their axons (Schöne et al., 2012; Figure 3); a subpopulation of SCN neurons (Ziegler et al., 2002; Kiss et al., 2007), consistent with observations that electrical or chemical stimulation in SCN can evoke ionotropic AMPA-NMDA glutamate receptor-mediated excitation in PVT neurons (Zhang et al., 2006b); prefrontal and other corticothalamic inputs.
Ionotropic Glutamate Receptors (GluRs)
Following electrical stimulation in local or more distant sites (e.g., area of SCN), PVT neurons display evoked excitatory postsynaptic currents (eEPSCs) or potentials (eEPSPs) that contain components attributed to both AMPA/KA and NMDA ionotropic receptor subtypes (see Figure 3 in Zhang et al., 2006b). Depending on the MP, eEPSPs can trigger a single action potential or a LTS-induced burst of action potentials (see Figure 5 in Zhang et al., 2006b). PVT neurons also display abundant spontaneous AMPA/KA receptor-mediated excitatory postsynaptic potentials (sEPSPs) that can contribute to RMPs and therefore support ongoing burst firing (see Figure 4 in Hermes and Renaud, 2011). Curiously, voltage clamp recordings reveal that the equivalent AMPA/KA receptor-mediated EPSCs show little change in their frequency in the presence of TTX (see Figure 4 in Hermes and Renaud, 2011)), suggesting that glutamatergic axons terminating on PVT neurons may have unique properties that allow significant stochastic or spontaneous release of glutamate from nerve terminals.
Metabotropic glutamate receptors (mGluRs) are a heterogeneous collection of C-type G protein-coupled receptors that are currently divided into three groups (I, II and III), each having a discrete CNS distribution (Niswender and Conn, 2010). Group II mGluRs are selectively found in limbic and forebrain regions, and their activation suppresses excitatory transmission in amygdala, bed nucleus of stria terminalis and prefrontal cortex (Lin et al., 2000; Marek et al., 2000; Grueter and Winder, 2005; Muly et al., 2007), sites known to receive a prominent innervation from PVT neurons. PVT neurons themselves also display a high expression of group II mGluRs (Ohishi et al., 1993; Gu et al., 2008) and a recent analysis (Hermes and Renaud, 2011) reveals that their postsynaptic activation by the selective group II mGluR orthosteric agonists LY379268 and DCG-IV induces membrane hyperpolarization, sufficient to suppress ongoing burst or tonic firing. In PVT, LY 379268 also activates presynaptic receptors to reduce ionotropic AMPA/KA receptor-mediated miniature excitatory postsynaptic currents (mEPSCs) arising from spontaneous synaptic release of glutamate. LY 487379, an mGluR2-positive allosteric modulator, potentiates both the postsynaptic and presynaptic actions of LY 379268 (Hermes and Renaud, 2011). These data support the notion that orthosteric activation or positive allosteric modulation of mGluR2s in PVT and midline thalamus may contribute to a reduction in excitatory neurotransmission to limbic and forebrain regions. This action may be a component of the central mechanisms underlying the beneficial effects of mGluR2-interacting drugs in animal models of anxiety and psychosis, disorders believed to result from aberrant or excessive glutamatergic neurotransmission (Swanson et al., 2005; Conn et al., 2009; Niswender and Conn, 2010).
Many immunohistochemical studies reveal a prominent monoaminergic innervation to midline thalamus. PVT in particular receives noradrenergic fibers from locus coeruleus neurons, adrenergic and dopaminergic innervations from several brainstem and hypothalamic cell groups, and a serotonin innervation from the dorsal and median raphe nuclei (Lindvall et al., 1974; Swanson and Hartman, 1975; Cropper et al., 1984; Otake and Ruggerio, 1995). The midline and intralaminar thalamus is relatively rich in receptors and transporters for monoamines, however there is limited information on their presynaptic and/or postsynaptic localization or on their influence on membrane excitability and rapid neurotransmission. In the tree shrew, chronic psychosocial stress is reported to upregulate α2 receptors in PVT, and exposure of PVT neurons to noradrenaline elicits membrane depolarization mediated via postsynaptic α1 receptors and a GIRK conductance-mediated hyperpolarization via postsynaptic α2 receptors (Heilbronner et al., 2004; Heilbronner and Flügge, 2005).
Postsynaptic monoaminergic receptors can influence additional conductances beyond those that regulate MP. A notable example is their ability to modulate sAHPs and thereby change neuronal excitability (Haas and Konnerth, 1983; Madison and Nicoll, 1984; Pedarzani and Storm, 1993). This also applies to both types of sAHP that are observed in PVT neurons. The LTS-induced sAHP is significantly suppressed by isoproterenol, a β-adrenoceptor agonist, 5-CT, a serotonin 5HT7 receptor agonist, and by stimulation of the cAMP/protein kinase A signaling pathway (Zhang et al., 2009). In addition, Goaillard and Vincent (2002) reported suppression of the spike train-induced sAHP in midline and intralaminar thalamic neurons by a selective 5-HT7 agonist, an effect mediated by the cAMP messenger pathway. We recently reported that the spike train-induced sAHP in PVT neurons can be suppressed by transmitter molecules that engage either the cAMP or the PKC signaling cascade (Zhang et al., 2010).
Various neuropeptide transmitters and their receptors have been reported in PVT (Tables 1 and 2), but relatively few have been evaluated for their influence on neuronal excitability.
Table 1. Summary table of electrophysiologically characterized postsynaptic neurotransmitter receptors in PVT neurons.
Table 2. Table 2. Summary table of additional neurotransmitter G-protein coupled receptors expressed in PVT neurons. Most data refer to receptor mRNA analyses. Receptor densities are directly copied from actual references.
Arginine vasopressin (AVP)
Fibers displaying AVP-like immunoreactivity are present throughout the rostrocaudal extent of PVT, and arise almost exclusively from AVP synthesizing neurons located in the dorsomedial part of the SCN (Buijs et al., 1978; Sofroniew and Weindl, 1978; Watts and Swanson, 1987). PVT neurons exposed to bath-applied AVP respond with a TTX-resistant membrane depolarization, blockable by prior application of a selective V1a receptor antagonist, and not replicated by a specific V2 receptor type agonist (Zhang et al., 2006a). The AVP-induced response is associated with reduction in an inward rectifier K+ conductance. In addition, after correction of the AVP induced membrane depolarization through intracellular injection of negative current, an increase in the LTS duration and number of superimposed Na+ spikes may reflect a change in an LTS-associated nonselective cation conductance (see Figure 3 in Zhang et al., 2006a). Interestingly these AVP-induced effects are more prevalent in neurons recorded from posterior PVT suggesting heterogeneity along the rostral-caudal axis. Since AVP release from SCN provides an important circadian output signal for regulating neuroendocrine rhythms (see Kalsbeek et al., 2010 for review), its release from synaptic terminals in PVT may serve to mediate rhythmic information to the limbic system.
Gastrin-releasing peptide (GRP)
GRP, a 27-amino acid peptide, and the decapeptide neuromedin B (NMB) are mammalian analogues of the amphibian bombesin (BB) and BB-like peptides present in brain (Jensen et al., 2008). Central GRP and its receptor have been implicated in a variety of functions, notably feeding, circadian rhythms, emotion, fear-related memory processing, itch sensation and sexual behavior (Moody and Merali, 2004; Sun and Chen, 2007; Sakamoto et al., 2008). In addition, GRP receptor expression and signaling may have a role in CNS disorders that include anxiety, autism, memory dysfunction and brain tumors (reviewed in Roesler and Schwartsmann, 2012). Initial studies using autoradiography revealed a high density of BB binding in PVT and in centromedial, paracentral and other intralaminar thalamic nuclei (Zarbin et al., 1985). With immunocytochemistry, fibers displaying GRP-like immunoreactivity have also been reported in PVT and select midline and intralaminar nuclei (Mikkelsen et al., 1991; Hermes et al., 2013). A recent electrophysiological investigation (Hermes et al., 2013) revealed that >90% of PVT neurons exposed to nanomolar concentrations of GRP respond with a TTX-resistant postsynaptic membrane depolarization. GRP-induced depolarizations appear to be associated with two patterns of firing: one population of PVT neurons with relatively hyperpolarized RMPs responded with sequences of LTS-mediated bursts of action potentials recurring at low frequencies; another population of PVT neurons with more depolarized RMPs responded with tonic firing. GRP’s effects in PVT are mediated selectively by postsynaptic BB type 2 (BB2) receptors, consistent with the nanomolar affinity of BB2 receptors for GRP (Jensen et al., 2008). While these findings contrast with those from earlier investigations that reported an absence of BB2 receptors in midline and intralaminar thalamus (Ladenheim et al., 1992; Wada et al., 1992), more recent data obtained in mouse brain1 support the existence of BB2 receptors in these regions of the thalamus.
Voltage-clamp analysis suggests that GRP’s activation of PVT neurons involves two ionic mechanisms: suppression of a Ba2+-sensitive, presumably Kir2 type, inward rectifier K+ conductance, and concomitant activation of a nonselective cation conductance with a transient receptor potential (TRP) vanilloid 1 (TRPV1)-like pharmacological profile (Hermes et al., 2013). TRPV1-expression has been reported, and disputed, in midline and intralaminar thalamus (Mezey et al., 2000; Roberts et al., 2004; Cavanaugh et al., 2011). Importantly, application of a selective TRPV1 antagonist (SB 366791) can be seen to reduce GRP-induced membrane depolarization and rhythmic burst or tonic firing, implying that activation of a TRPV1-like conductance does indeed contribute significantly to GRP-induced increases in PVT neuronal excitability. We (Hermes et al., 2013) have cautiously applied the term “TRPV1-like” to this action since some biophysical properties differ from previously reported TRPV1 features, possibly because TRPV1 forms heteromers with other TRPV channel subunits or members of a different TRP family, or is a splice variant of TRPV1 that has different functional properties. The origin of GRP immunoreactive fibers in midline thalamus likely includes a subpopulation of SCN neurons where GRP is a co-existing neuropeptide (van den Pol and Tsujimoto, 1985), raising speculation that the described membrane actions could in part mediate circadian-related information to the limbic system.
Orexin A (hypocretinA) and orexin B (hypocretinB) are neuropeptides synthesized by a select population of lateral hypothalamic-perifornical neurons whose axons display a wide but selective CNS distribution (de Lecea et al., 1998; Sakurai et al., 1998). Two G protein-coupled orexin receptors, OXR1 and OXR2, have been characterized and their distribution mapped (Marcus et al., 2001). Since their discovery, orexins have been shown to participate in multiple physiological functions, including vigilance and arousal, feeding and energy homeostasis, reward-motivated behaviors and stress responses (reviewed in Kukkonen, 2013). Electrophysiological data from neurons in different brain regions verify that activation of orexin receptors potently enhances neuronal excitability (Kukkonen, 2013). It is notable that the midline thalamus, and PVT in particular, receives one of the most dense orexinergic innervations in the CNS (Peyron et al., 1998; Figure 3). PVT contains both OXR1 and OXR2 (Marcus et al., 2001). Consistent with this distribution of orexin fibers and receptor are electrophysiological findings that subpopulations of neurons in the midline thalamic nuclei, but not in ventrolateral thalamus, respond to both orexin A and orexin B (Bayer et al., 2002). Responsive neurons exhibit membrane depolarization when exposed to low nanomolar concentrations of orexins, with orexin B appearing more potent than orexin A in reducing a postsynaptic membrane K+ conductance (Bayer et al., 2002; Ishibashi et al., 2005; Govindaiah and Cox, 2006; Huang et al., 2006; Kolaj et al., 2007). Our observations in PVT neurons exposed to high nanomolar concentrations of either orexin A or orexin B indicate that orexin receptor activation results in reduction in one or more K+ conductances that include TASK-like channels, and increase in a nonselective cation conductance (Kolaj et al., 2007; Doroshenko and Renaud, 2009). Orexin-induced responses depend on both the cell’s MP and the amplitude of the induced depolarization to achieve either burst or tonic firing; an associated increase in the LTS duration promotes a significant increase in the number of superimposed action potentials (see Figure 4 in Kolaj et al., 2007). We recently reported that orexin A also suppressed the Ca2+-dependent (KCa) and Na+-dependent (KNa) components of the spike train-induced sAHP (Zhang et al., 2009) and the LTS-induced sAHP (Zhang et al., 2010). Thus, as schematically shown in Figure 3, suppression of sAHPs adds a novel dimension to the manner whereby orexins can enhance excitability in PVT neurons, potentially expanding the response elicited by release of glutamate, a co-existing transmitter in orexin-synthesizing neurons (see Schöne et al., 2012). Of note, it has recently been proposed that OXR1 and OXR2 might engage different signaling pathways and thus may have distinctly different actions (e.g., Mieda et al., 2013; Xu et al., 2013). No doubt the availability of receptor selective antagonists (Lebold et al., 2013) will facilitate further investigation into potential differential actions of these peptides (e.g., Xu et al., 2013).
Thyrotropin releasing hormone (TRH)
TRH, the first hypothalamic releasing factor to be isolated and characterized in the late 1960s, is present in multiple extrahypothalamic brain areas where it has a role in arousal, mood and cognition (see reviews by Lechan and Fekete, 2006; Yarbrough et al., 2007). TRH and TRH analogs are also being evaluated for their therapeutic potential in areas of neuroprotection, psychiatric and mood disorders, narcolepsy and certain forms of epilepsy (Gary et al., 2003; Yarbrough et al., 2007). Among CNS sites displaying a high density of TRH binding and mRNA expression for TRH receptors is the midline thalamus, with PVT exhibiting mRNA for both presently known receptors, TRHR1 and TRHR2 (Heuer et al., 2000). Since little is known of its actions at the cellular level in midline thalamus, we recently explored the response of PVT and neighboring central medial thalamic neurons to exogenous application of TRH and a TRH analog, taltirelin (Zhang et al., 2013). The data indicated that >90% of PVT neurons responded to nanomolar concentrations of TRH, and taltirelin, with a desensitizing G protein-mediated membrane depolarization and inward current that involved suppression of a GIRK-like inward rectifier K+ conductance and activation of a transient receptor potential, canonical (TRPC)-like nonselective cation conductance, possibly involving TRPC4/C5 subunits. Similar to observations with AVP, orexins and GRP, the enhanced excitability of PVT neurons to TRH also included a marked enhancement of LTS-evoked firing, a feature that was significantly attenuated in the presence of putative TRPC blockers. Although, no specific TRH receptor antagonists have yet been identified, pretreatment with the benzodiazepine chlordiazepoxide, considered as a competitive TRH receptor antagonist in the adenohypophysis where only TRHR1 is present (Sun et al., 2003), significantly reduced the TRH-induced inward current in PVT. In addition, in neighboring central medial nucleus, where only TRHR2 mRNA has been reported (Heuer et al., 2000), a response to TRH required significantly higher concentrations of the peptide and lacked sensitivity to chlordiazepoxide, supporting the notion that TRHR1 mediates the response to TRH in PVT neurons. TRH-immunoreactive axons detected in PVT originate in part from TRH synthesizing neurons in hypothalamus and brainstem (Merchenthaler et al., 1988; Wittmann et al., 2009), suggesting that TRH may contribute in the integration of the metabolic and energy sensing functions of the hypothalamus with motivated behavior functions attributed to midline thalamus.
Summary and Perspectives
A growing body of literature attests to the involvement of midline and intralaminar thalamic neurons in various distinct functions and behaviors, including vigilance and arousal, nociception, stress responses and motivated behaviors. Comparatively little is known about the intrinsic cellular properties and neuropharmacology of neurons in this area of CNS, fundamental for a full understanding of midline and intralaminar thalamic function. We have reviewed present knowledge on the cellular physiology and pharmacology of neurons in PVT, a stable midline thalamic structure throughout mammalian evolution. PVT appears to be a nodal point in CNS circuits related to salt appetite, energy balance and food reward, and where neurons display exceptional sensitivity (early gene expression) to stress and arousal. Data derived from patch clamp recordings in brain slices provide insights on properties of PVT neurons, some of which are not detectable in neurons sampled in VB and reticular thalamic nuclei.
RMP of PVT neurons is maintained by K+ channels, including inward rectifier (Kir) and two pore domain (TASK-like) channels, and by HCN channels. These channels also participate in a diurnal fluctuation in RMP of PVT neurons, with an additional change in properties of LVA T-type Ca2+ channels contributing to an increase in spontaneous burst firing during the night period, when rodents are most active. The mechanisms underlying these diurnal changes remain undefined, but are likely to involve an influence of SCN circadian pacemaker neurons which directly innervate PVT neurons.
PVT and a sample of midline thalamic neurons display two types of apamin-resistant sAHPs that may prove to be a defining characteristic of neurons in this area of brain, given that they are not seen in neurons sampled in thalamic VB or reticular nuclei. A TTX-sensitive spike train-induced sAHP is produced by KCa channels with unusual pharmacological characteristics and, at higher levels of activity, by KNa channels. Another is a TTX-resistant LTS-induced sAHP that is mediated by K+ channels insensitive to known specific KCa channel blockers. Both types of sAHP are subject to modulation by activation of neurotransmitter receptors, suggesting that they may play an important role in regulating neuronal excitability in the midline (and possibly intralaminar) thalamus.
A comparison of receptors currently under investigation in PVT (Table 1) with all the receptors presently known to be expressed in PVT (Table 2) indicates that we are in the early stages of understanding the properties and neuropharmacology of PVT neurons. Investigations to date (Table 1) have established mainly the postsynaptic actions mediated by specific transmitter receptors for GABA, glutamate, several monoamines and peptide neurotransmitters, with more to come. Whereas the focus here has been on PVT, the intrinsic properties and neuropharmacology of neurons in other midline and intralaminar nuclei also need to be characterized. These initial observations attest to some fundamental functional differences between midline and lateral/reticular thalamic neurons. Since specific regions of the midline and intralaminar thalamus can be associated with specific behaviors, there is a high probability of detecting different characteristics at the cellular level. Thus, this review represents a work in progress, with the prospects that the introduction of newer technologies (e.g., optogenetics) and animal models to in-vivo and in-vitro investigations will bring us to a better understanding of this relatively unexplored region of the mammalian thalamus.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.
The research reported from the authors lab was supported by the Canadian Institutes of Health Research (grant MOP 77745). LRP holds the GSK/CIHR/ J David Grimes Chair at the University of Ottawa.
Arcelli, P., Frassoni, C., Regondi, M. C., De Biasi, S., and Spreafico, R. (1997). GABAergic neurons in mammalian thalamus: a marker of thalamic complexity? Brain Res. Bull. 42, 27–37. doi: 10.1016/s0361-9230(96)00107-4
Bayer, L., Eggermann, E., Saint-Mieux, B., Machard, D., Jones, B. E., Mühlethaler, M., et al. (2002). Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J. Neurosci. 22, 7835–7839.
Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., and Cope, D. W. (2009). Extrasynaptic GABAA receptors: form, pharmacology, and function. J. Neurosci. 29, 12757–12763. doi: 10.1523/JNEUROSCI.3340-09.2009
Benarroch, E. E. (2008). The midline and intralaminar thalamic nuclei: anatomic and functional specificity and implications in neurologic disease. Neurology 71, 944–949. doi: 10.1212/01.wnl.0000326066.57313.13
Berendse, H. W., and Groenewegen, H. J. (1990). Organization of the thalamocortical projections in the rat, with special emphasis on the ventral striatum. J. Comp. Neurol. 299, 187–228. doi: 10.1002/cne.902990206
Betley, J. N., Cao, Z. F. H., Ritola, K. D., and Sternson, S. M. (2013). Parallel, redundant circuit organization for homeostatic control of feeding behavior. Cell 155, 1337–1350. doi: 10.1016/j.cell.2013.11.002
Bettler, B., Kaupmann, K., Mosbacher, J., and Gassman, M. (2004). Molecular structure and physiological functions of GABAB receptors. Physiol. Rev. 84, 835–867. doi: 10.1152/physrev.00036.2003
Bhatnagar, S., Huber, R., Nowak, N., and Trotter, P. (2002). Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint. J. Neuroendocrinol. 14, 403–410. doi: 10.1046/j.0007-1331.2002.00792.x
Bhatnagar, S., Viau, V., Chu, A., Soriano, L., Meijer, O. C., and Dallman, M. F. (2000). A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function. J. Neurosci. 20, 5564–5573.
Bhattacharjee, A., Gan, L., and Kaczmarek, L. K. (2002). Localization of the slack potassium channel in the rat central nervous system. J. Comp. Neurol. 454, 241–254. doi: 10.1002/cne.10439
Bhattacharjee, A., and Kaczmarek, L. K. (2005). For K+ channels, Na+ is the new Ca2+. Trends Neurosci. 28, 422–428. doi: 10.1016/j.tins.2005.06.003
Bhattacharjee, A., von Hehn, C. A. A., Mei, X., and Kaczmarek, L. K. (2005). Localization of the Na+-activated K+ channel slick in the rat central nervous system. J. Comp. Neurol. 484, 80–92. doi: 10.1002/cne.20462
Biel, M., Wahl-Schott, C., Michalakis, S., and Zong, X. (2009). Hyperpolarization-activated cation channels: from genes to function. Physiol. Rev. 89, 847–885. doi: 10.1152/physrev.00029.2008
Blethyn, K. L., Hughes, S. W., Tóth, T. I., Cope, D. W., and Crunelli, V. (2006). Neuronal basis of the slow (<1 Hz) oscillation in neurons of the nucleus reticularis thalami in vitro. J. Neurosci. 26, 2474–2486. doi: 10.1523/jneurosci.3607-05.2006
Bloom, F., Battenberg, E., Rossier, J., Ling, N., and Guillemin, R. (1978). Neurons containing β-endorphin in rat exist separately from those containing enkephalin: immunocytochemical studies. Proc. Natl. Acad. Sci. U S A 75, 1591–1595. doi: 10.1073/pnas.75.3.1591
Brinkley, S. G., and Mody, I. (2012). Extrasynaptic GABAA receptors: their function in the CNS and implications for disease. Neuron 73, 23–34. doi: 10.1016/j.neuron.2011.12.012
Browning, J. R., Jansen, H. T., and Sorg, B. A. (2014). Inactivation of the paraventricular thalamus abolishes the expression of cocaine conditioned place preference in rats. Drug Alcohol Depend. 134, 387–390. doi: 10.1016/j.drugalcdep.2013.09.021
Brunton, J., and Charpak, S. (1998). µ-opioid peptides inhibit thalamic neurons. J. Neurosci. 18, 1671–1678.
Buijs, R. M., Swaab, D. F., Dogterom, J., and Van Leeuwen, F. W. (1978). Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Cell Tissue Res. 186, 423–433. doi: 10.1007/BF00224932
Cansell, C., Denis, R. G. P., Joly-Amado, A., Castel, J., and Luquet, S. (2012). Arcuate AgRP neurons and the regulation of energy balance. Front. Endocrinol. (Lausanne) 3:169. doi: 10.3389/fendo.2012.00169
Cavanaugh, D. J., Chesler, A. T., Jackson, A. C., Sigal, Y. M., Yamanaka, H., Grant, R., et al. (2011). Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J. Neurosci. 31, 5067–5077. doi: 10.1523/JNEUROSCI.6451-10.2011
Chen, Y., Brunson, K. L., Müller, M. B., Cariaga, W., and Baram, T. Z. (2000). Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J. Comp. Neurol. 420, 305–323. doi: 10.1002/(sici)1096-9861(20000508)420:3<305::aid-cne3>3.0.co;2-8
Cheng, M. Y., Leslie, F. M., and Zhou, Q. Y. (2006). Expression of prokineticins and their receptors in the adult mouse brain. J. Comp. Neurol. 498, 796–809. doi: 10.1002/cne.21087
Chen, W.-K., Liu, I. Y., Chang, Y.-T., Chen, Y.-C., Chen, C.-C., Yen, C.-T., et al. (2010). Cav3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain. J. Neurosci. 30, 10360–10368. doi: 10.1523/JNEUROSCI.1041-10.2010
Christie, M. J., Summers, R. J., Stephenson, J. A., Cook, C. J., and Beart, P. M. (1987). Excitatory amino acid projections to the nucleus accumbens septi in the rat: a retrograde transport study utilizing D [3H] aspartate and [3H] GABA. Neuroscience 22, 425–439. doi: 10.1016/0306-4522(87)90345-9
Conn, P. J., Lindsley, C. W., and Jones, C. K. (2009). Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol. Sci. 30, 25–31. doi: 10.1016/j.tips.2008.10.006
Cropper, E. C., Eisenman, J. S., and Azmitia, E. C. (1984). An immunocytochemical study of the serotonergic innervation of the thalamus of the rat. J. Comp. Neurol. 224, 38–50. doi: 10.1002/cne.902240104
Crunelli, V., Tóth, T. I., Cope, D. W., Blethyn, K., and Hughes, S. W. (2005). The ‘window’ T-type calcium current in brain dynamics of different behavioural states. J. Physiol. 562, 121–129. doi: 10.1113/jphysiol.2004.076273
Csáki, A., Kocsis, K., Halász, B., and Kiss, J. (2000). Localization of glutamatergic/aspartatergic neurons projecting to the hypothalamic paraventricular nucleus studied by retrograde transport of [3H] D-aspartate autoradiography. Neuroscience 101, 637–655. doi: 10.1016/s0306-4522(00)00411-5
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X., Foye, P. E., Danielson, P. E., et al. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U S A 95, 322–327. doi: 10.1073/pnas.95.1.322
Ding, Y. Q., Kaneko, T., Nomura, S., and Mizuno, N. (1996). Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J. Comp. Neurol. 367, 375–402. doi: 10.1002/(SICI)1096-9861(19960408)367:3<375::AID-CNE5?3.0.CO;2-2
Doroshenko, P., and Renaud, L. P. (2009). Acid-sensitive TASK-like K+ conductances contribute to resting membrane potential and to orexin-induced membrane depolarization in rat thalamic paraventricular nucleus neurons. Neuroscience 158, 1560–1570. doi: 10.1016/j.neuroscience.2008.12.008
Faber, E. S., and Sah, P. (2003). Calcium-activated potassium channels: multiple contributions to neuronal function. Neuroscientist 9, 181–194. doi: 10.1177/1073858403009003011
Farrant, M., and Nusser, Z. (2005). Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors. Nat. Rev. Neurosci. 6, 215–229. doi: 10.1038/nrn1625
Fremeau, R. T., Kam, K., Qureshi, T., Johnson, J., Copenhagen, D. R., Storm-Matheson, J., et al. (2004). Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304, 1815–1819. doi: 10.1126/science.1097468
Gary, K. A., Sevarino, K. A., Yarbrough, G. G., Prange, A. J. Jr., and Winokur, A. (2003). The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J. Pharmacol. Exp. Ther. 305, 410–416. doi: 10.1124/jpet.102.044040
Gassmann, M., and Bettler, B. (2012). Regulation of neuronal GABAB receptor functions by subunit composition. Nat. Rev. Neurosci. 13, 380–394. doi: 10.1038/nrn3249
George, S. R., Zastawny, R. L., Briones-Urbina, R., Cheng, R., Nguyen, T., Heiber, M., et al. (1994). Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem. Biophys. Res. Commun. 205, 1438–1444. doi: 10.1006/bbrc.1994.2826
Glykys, J., and Mody, I. (2007). Activation of GABAA receptors: views from outside the synaptic cleft. Neuron 56, 763–770. doi: 10.1016/j.neuron.2007.11.002
Goaillard, J.-M., and Vincent, P. (2002). Serotonin suppresses the slow afterhyperpolarization in rat intralaminar and midline thalamic neurons by activating 5-HT7 receptors. J. Physiol. 541, 453–465. doi: 10.1113/jphysiol.2001.013896
Goldstein, S. A. N., Bockenhauer, D., O’Kelly, I., and Zilberberg, N. (2001). Potassium leak channels and the KCNK family of two-P-domain subunits. Nat. Rev. Neurosci. 2, 175–184. doi: 10.1038/35058574
Gong, J. P., Onaivi, E. S., Ishiguro, H., Liu, Q. R., Tagliaferro, P. A., Brusco, A., et al. (2006). Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 1071, 10–23. doi: 10.1016/j.brainres.2005.11.035
Govindaiah, G., and Cox, C. L. (2006). Modulation of thalamic excitability by orexins. Neuropharmacology 51, 414–425. doi: 10.1016/j.neuropharm.2006.03.030
Groenewegen, H. J., and Berendse, H. W. (1994). The specificity of the ‘nonspecific’ midline and intralaminar thalamic nuclei. Trends Neurosci. 17, 52–57. doi: 10.1016/0166-2236(94)90074-4
Grueter, B. A., and Winder, D. G. (2005). Group II and III metabotropic glutamate receptors suppress excitatory synaptic transmission in the dorsolateral bed nucleus of the stria terminalis. Neuropsychopharmacology 30, 1302–1311. doi: 10.1038/sj.npp.1300672
Gu, G., Lorrain, D. S., Wei, H., Cole, R. L., Zhang, X., Daggett, L. P., et al. (2008). Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: implication in emotional responses and central disinhibition. Brain Res. 1197, 47–62. doi: 10.1016/j.brainres.2007.12.057
Haas, H. L., and Konnerth, A. (1983). Histamine and noradrenaline decrease calcium-activated potassium conductance in hippocampal pyramidal cells. Nature 302, 432–434. doi: 10.1038/302432a0
Heilbronner, U., and Flügge, G. (2005). Modulation of neurons in the paraventricular thalamic nucleus by α2 adrenoceptor agonists: evidence for physiological and morphological heterogeneity. Thalamus Relat. Syst. 3, 293–303. doi: 10.1017/s1472928807000313
Heilbronner, U., van Kampen, M., and Flügge, G. (2004). The alpha-2B adrenoceptor in the paraventricular thalamic nucleus is persistently upregulated by chronic psychosocial stress. Cell. Mol. Neurobiol. 24, 815–831. doi: 10.1007/s10571-004-6921-z
Henny, P., Brischoux, F., Mainville, L., Stroh, T., and Jones, B. E. (2010). Immunohistochemical evidence for synaptic release of glutamate from orexin terminals in the locus coeruleus. Neuroscience 169, 1150–1157. doi: 10.1016/j.neuroscience.2010.06.003
Hermes, M. L. H. J., Kolaj, M., Coderre, E., and Renaud, L. P. (2013). Gastrin-releasing peptide acts via postsynaptic BB2 receptors to modulate inward rectifier K+ and TRPV1-like conductances in rat paraventricular thalamic neurons. J. Physiol. 591, 1823–1839. doi: 10.1113/jphysiol.2012.249227
Hermes, M. L. H. J., and Renaud, L. P. (2011). Post- and presynaptic group II metabotropic glutamate receptor activation reduces neuronal excitability in rat midline paraventricular thalamic neurons. J. Pharmacol. Exp. Ther. 336, 840–849. doi: 10.1124/jpet.110.176149
Heuer, H., Schäfer, M. K.-H., O’Donnell, D., Walker, P., and Bauer, K. (2000). Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J. Comp. Neurol. 428, 319–336. doi: 10.1002/1096-9861(20001211)428:2<319::aid-cne10>3.0.co;2-9
Hewitt, S. A., Wamsteeker, J. I., Kurz, E. U., and Bains, J. S. (2009). Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis. Nat. Neurosci. 12, 438–443. doi: 10.1038/nn.2274
Hibino, H., Inanobe, A., Furutani, K., Murakami, S., Findlay, I., and Kurachi, Y. (2010). Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol. Rev. 90, 291–366. doi: 10.1152/physrev.00021.2009
Horvath, T. L., Bechmann, I., Naftolin, F., Kalra, S. P., and Leranth, C. (1997). Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res. 756, 283–286. doi: 10.1016/s0006-8993(97)00184-4
Hsu, D. T., and Price, J. L. (2009). Paraventricular thalamic nucleus: subcortical connections and innervation by serotonin, orexin, and corticotrophin-releasing hormone in macaque monkeys. J. Comp. Neurol. 512, 825–848. doi: 10.1002/cne.21934
Huang, H., Ghosh, P., and van den Pol, A. N. (2006). Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal. J. Neurophysiol. 95, 1656–1668. doi: 10.1152/jn.00927.2005
Huguenard, J. R. (1996). Low threshold calcium currents in central nervous system neurons. Annu. Rev. Physiol. 58, 329–348. doi: 10.1146/annurev.physiol.58.1.329
Hur, E. E., and Zaborszky, L. (2005). Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization. J. Comp. Neurol. 483, 351–373. doi: 10.1002/cne.20444
Ishibashi, M., Takano, S., Yanagida, H., Takatsuna, M., Nakajima, K., Oomura, Y., et al. (2005). Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro. Peptides 26, 471–481. doi: 10.1016/j.peptides.2004.10.014
Jelsing, J., Larsen, P. J., and Vrang, N. (2008). Identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry. Neuroscience 154, 641–652. doi: 10.1016/j.neuroscience.2008.03.051
Jensen, R. T., Battey, J. F., Spindel, E. R., and Benya, R. V. (2008). International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol. Rev. 60, 1–42. doi: 10.1124/pr.107.07108
Jin, C. Y., Kalimo, H., and Panula, P. (2002). The histaminergic system in human thalamus: correlation of innervation to receptor expression. Eur. J. Neurosci. 15, 1125–1138. doi: 10.1046/j.1460-9568.2002.01951.x
Jin, C., Lintunen, M., and Panula, P. (2005). Histamine H(1) and H(3) receptors in the rat thalamus and their modulation after systemic kainic acid administration. Exp. Neurol. 194, 43–56. doi: 10.1016/j.expneurol.2005.01.012
Joo, K. M., Chung, Y. H., Kim, M. K., Nam, R. H., Lee, B. L., Lee, K. H., et al. (2004). Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2 and PAC1 receptor) in the rat brain. J. Comp. Neurol. 476, 388–413. doi: 10.1002/cne.20231
Kalsbeek, A., Fliers, E., Hofman, M. A., Swaab, D. F., and Buijs, R. M. (2010). Vasopressin and the output of the hypothalamic biological clock. J. Neuroendocrinol. 22, 362–372. doi: 10.1111/j.1365-2826.2010.01956.x
Kampe, J., Tschöp, M. H., Hollis, J. H., and Oldfield, B. J. (2009). An anatomic basis for the communication of hypothalamic, cortical and mesolimbic circuitry in the regulation of energy balance. Eur. J. Neurosci. 30, 415–430. doi: 10.1111/j.1460-9568.2009.06818.x
Kawano, J., Krout, K. E., and Loewy, A. D. (2001). Suprachiasmatic nucleus projections to the paraventricular thalamic nucleus of the rat. Thalamus Relat. Syst. 1, 197–202. doi: 10.1017/s147292880100019x
Kelley, A. E., Baldo, B. A., and Pratt, W. E. (2005). A proposed hypothalamic-thalamic-striatal axis for the integration of energy balance, arousal and food reward. J. Comp. Neurol. 493, 72–85. doi: 10.1002/cne.20769
Kiss, J., Halász, B., Csáki, A., Liposits, Z., and Hrabovszky, E. (2007). Vesicular glutamate transporter 2 protein and mRNA containing neurons in the hypothalamic suprachiasmatic nucleus of the rat. Brain Res. Bull. 74, 397–405. doi: 10.1016/j.brainresbull.2007.07.023
Kolaj, M., Doroshenko, P., Cao, X. Y., and Renaud, L. P. (2007). Orexin-induced modulation of state-dependent intrinsic properties in rat thalamic midline paraventricular nucleus neurons attenuates action potential patterning and frequency. Neuroscience 147, 1066–1075. doi: 10.1016/j.neuroscience.2007.05.018
Kolaj, M., Zhang, L., Ronnekleiv, O. K., and Renaud, L. P. (2012). Midline thalamic paraventricular nucleus neurons display diurnal variation in resting membrane potentials, conductances and firing patterns in vitro. J. Neurophysiol. 107, 1835–1844. doi: 10.1152/jn.00974.2011
Kukkonen, J. P. (2013). Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am. J. Physiol. Cell Physiol. 304, C2–C32. doi: 10.1152/ajpcell.00227.2012
Ladenheim, E. E., Jensen, R. T., Mantey, S. A., and Moran, T. H. (1992). Distinct distributions of two bombesin receptor subtypes in the rat central nervous system. Brain Res. 593, 168–178. doi: 10.1016/0006-8993(92)91305-x
Lebold, T. P., Bonaventure, P., and Shireman, B. T. (2013). Selective orexin receptor antagonists. Bioorg. Med. Chem. Lett. 23, 4761–4769. doi: 10.1016/j.bmcl.2013.06.057
Lechan, R. M., and Fekete, C. (2006). The TRH neuron: a hypothalamic integrator of energy metabolism. Prog. Brain Res. 153, 209–235. doi: 10.1016/s0079-6123(06)53012-2
Levey, A. I., Edmunds, S. M., Heilman, C. J., Desmond, T. J., and Frey, K. A. (1994). Localization of muscarinic M3 receptor protein and M3 receptor binding in rat brain. Neuroscience 63, 207–221. doi: 10.1016/0306-4522(94)90017-5
Li, S., and Kirouac, G. J. (2008). Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala. J. Comp. Neurol. 506, 263–287. doi: 10.1002/cne.21502
Li, S., and Kirouac, G. J. (2012). Sources of inputs to the anterior and posterior aspects of the paraventricular nucleus of the thalamus. Brain Struct. Funct. 217, 257–273. doi: 10.1007/s00429-011-0360-7
Lin, H. C., Wang, S. J., Luo, M. Z., and Gean, P. W. (2000). Activation of group II metabotropic glutamate receptors induces long-term depression of synaptic transmission in the rat amygdala. J. Neurosci. 20, 9017–9024.
Lindvall, A. A., Björklund, A., Nobin, A., and Stenevi, U. (1974). The adrenergic innervation of the rat thalamus as revealed by the glyoxylic acid fluorescence method. J. Comp. Neurol. 154, 317–347. doi: 10.1002/cne.901540307
Madison, D. V., and Nicoll, R. A. (1984). Control of the repetitive discharge of rat CA1 pyramidal neurons in vitro. J. Physiol. 354, 319–331.
Maingret, F., Patel, A. J., Lazdunski, M., and Honore, E. (2001). The endocannabinoid anandamide is a direct and selective blocker of the background K (+) channel TASK-1. EMBO J. 20, 47–54. doi: 10.1093/emboj/20.1.47
Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., et al. (2001). Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435, 6–25. doi: 10.1002/cne.1190
Margeta-Mitrovic, M., Mitrovic, I., Riley, R. C., Jan, L. Y., and Basbaum, A. I. (1999). Immunohistochemical localization of GABA (B) receptors in the rat central nervous system. J. Comp. Neurol. 405, 299–321. doi: 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6
Marek, G. J., Wright, R. A., Schoepp, D. D., Monn, J. A., and Aghajanian, G. K. (2000). Physiological antagonism between 5-hydroxytryptamine2A and group II metabotropic glutamate receptors in prefrontal cortex. J. Pharmacol. Exp. Ther. 292, 76–87.
Mash, D. C., and Potter, L. T. (1986). Autoradiographic localization of M1 and M2 muscarinic receptors in the rat brain. Neuroscience 19, 551–564. doi: 10.1016/0306-4522(86)90280-0
McCormick, D. A. (1992). Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog. Neurobiol. 39, 337–388. doi: 10.1016/0301-0082(92)90012-4
McCormick, D. A., and Bal, T. (1997). Sleep and arousal: thalamocortical mechanisms. Annu. Rev. Neurosci. 20, 185–215. doi: 10.1146/annurev.neuro.20.1.185
McCormick, D. A., and Pape, H. C. (1990). Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillation in thalamic relay neurons. J. Physiol. 431, 291–318.
McKay, B. E., McRory, J. E., Molineux, M. L., Hamid, J., Snutch, T. P., Zamponi, G. W., et al. (2006). Cav3 T-type calcium channel isoforms differentially distribute to somatic and dendritic compartments in rat central neurons. Eur. J. Neurosci. 24, 2581–2594. doi: 10.1111/j.1460-9568.2006.05136.x
Merchenthaler, I., Csernus, V., Csontos, C., Petrusz, P., and Mess, B. (1988). New data on the immunocytochemical localization of thyrotropin-releasing hormone in the rat central nervous system. Am. J. Anat. 181, 359–376. doi: 10.1002/aja.1001810404
Mestikawy, S. E., Wallén-Mackenzie, Å., Fortin, G. M., Descarries, L., and Trudeau, L.-E. (2011). From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat. Rev. Neurosci. 12, 204–216. doi: 10.1038/nrn2969
Meuth, S. G., Aller, M. I., Munsch, T., Schuhmacher, T., Seidenbecher, T., Meuth, P., et al. (2006). The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. Mol. Pharmacol. 69, 1468–1476. doi: 10.1124/mol.105.020594
Mezey, E., Tóth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., et al. (2000). Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U S A 97, 3655–3660. doi: 10.1073/pnas.97.7.3655
Mieda, M., Tsujino, N., and Sakurai, T. (2013). Differential roles of orexin receptors in the regulation of sleep/wakefulness. Front. Endocrinol. (Lausanne) 4:57. doi: 10.3389/fendo.2013.00057
Mikkelsen, J. D., Larsen, P. J., O’Hare, M. M. T., and Wiegand, S. J. (1991). Gastrin releasing peptide in the rat suprachiasmatic nucleus: an immunohistochemical, chromatographic and radioimmunological study. Neuroscience 40, 55–66. doi: 10.1016/0306-4522(91)90174-m
Mitra, S. W., Hoskin, E., Yudkovitz, J., Pear, L., Wilkinson, H. A., Hayashi, S., et al. (2003). Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 144, 2055–2067. doi: 10.1210/en.2002-221069
Moga, M. M., Weis, R. P., and Moore, R. Y. (1995). Efferent projections of the paraventricular thalamic nucleus in the rat. J. Comp. Neurol. 359, 221–238. doi: 10.1002/cne.903590204
Monteggia, L. M., Eisch, A. J., Tang, M. D., Kaczmarek, L. K., and Nestler, E. J. (2000). Cloning and localization of the hyperpolarization-activated cyclic nucleotide-gated channel family in rat brain. Brain Res. Mol. Brain Res. 81, 129–139. doi: 10.1016/s0169-328x(00)00155-8
Moody, T. W., and Merali, Z. (2004). Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications. Peptides 25, 511–520. doi: 10.1016/j.peptides.2004.02.012
Moore, R. Y., and Speh, J. C. (1993). GABA is the principal neurotransmitter of the circadian system. Neurosci. Lett. 150, 112–116. doi: 10.1016/0304-3940(93)90120-a
Morimoto, M., Morita, N., Ozawa, H., Yokoyama, K., and Kawata, M. (1996). Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neurosci. Res. 26, 235–269. doi: 10.1016/s0168-0102(96)01105-4
Muly, E. C., Mania, I., Guo, J. D., and Rainnie, D. G. (2007). Group II metabotropic glutamate receptors in anxiety circuitry: correspondence of physiological response and subcellular distribution. J. Comp. Neurol. 505, 682–700. doi: 10.1002/cne.21525
Neto, F. L., Schadrack, J., Berthele, A., Zieglgänsberger, W., Tölle, T. R., and Castro-Lopes, J. M. (2000). Differential distribution of metabotropic glutamate receptor subtype mRNA in the thalamus of the rat. Brain Res. 854, 93–105. doi: 10.1016/s0006-8993(99)02326-4
Niswender, C. M., and Conn, P. J. (2010). Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol. 50, 295–322. doi: 10.1146/annurev.pharmtox.011008.145533
Notomi, T., and Shigemoto, R. (2004). Immunohistochemical localization of Ih channel subunits, HCN14, in the rat brain. J. Comp. Neurol. 471, 241–276. doi: 10.1002/cne.11039
Novak, C. M., and Nunez, A. A. (1998). Daily rhythms in Fos activity in the rat ventrolateral preoptic area and midline thalamic nuclei. Am. J. Physiol. 275, R1620–R1626.
Ochiishi, T., Chen, L., Yukawa, A., Saitoh, Y., Sekino, Y., Arai, T., et al. (1999). Cellular localization of adenosine A1 receptors in rat forebrain: immunohistochemical analysis using adenosine A1 receptor-specific monoclonal antibody. J. Comp. Neurol. 411, 301–316. doi: 10.1002/(sici)1096-9861(19990823)411:2<301::aid-cne10>3.0.co;2-h
Ohishi, H., Shigemoto, R., Nakanishi, S., and Mizuno, N. (1993). Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53, 1009–1018. doi: 10.1016/0306-4522(93)90485-x
Otake, K., and Ruggerio, D. A. (1995). Monoamines and nitric oxide are employed by afferents engaged in midline thalamic regulation. J. Neurosci. 15, 1891–1911.
Ottersen, O. P., and Storm-Mathisen, J. (1984). GABA-containing neurons in the thalamus and pretectum of the rodent. An immunocytochemical study. Anat. Embryol. (Berl) 170, 197–207. doi: 10.1007/bf00319005
Parker, R. M., and Herzog, H. (1999). Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11, 1431–1448. doi: 10.1046/j.1460-9568.1999.00553.x
Parsons, M. P., Li, S., and Kirouac, G. J. (2006). The paraventricular nucleus of the thalamus as an interface between the orexin and CART peptides and the shell of the nucleus accumbens. Synapse 59, 480–490. doi: 10.1002/syn.20264
Patel, A. J., and Honoré, E. (2001). Properties and modulation of mammalian 2P domain K+ channels. Trends Neurosci. 24, 339–346. doi: 10.1016/s0166-2236(00)01810-5
Paxinos, G., and Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates. 4th Edn. San Diego, CA: Academic Press.
Pedarzani, P., and Storm, J. F. (1993). PKA mediates the effects of monoamine transmitters on the K+ current underlying the slow spike frequency adaptation in hippocampal neurons. Neuron 11, 1023–1035. doi: 10.1016/0896-6273(93)90216-e
Peng, Z. C., and Bentivoglio, M. (2004). The thalamic paraventricular nucleus relays information from the suprachiasmatic nucleus to the amygdala: a combined anterograde and retrograde tracing study in the rat at the light and electron microscope levels. J. Neurocytol. 33, 101–116. doi: 10.1023/b:neur.0000029651.51195.f9
Peng, Z. C., Zucconi, G. G., and Bentivoglio, M. (1995). Fos-related protein expression in the thalamic midline paraventricular nucleus of the rat thalamus: basal oscillation and relationship with limbic afferents. Exp. Brain Res. 104, 21–29. doi: 10.1007/bf00229852
Perez-Reyes, E. (2003). Molecular physiology of low-voltage-activated T-type calcium channels. Physiol. Rev. 83, 117–161. doi: 10.1152/physrev.00018.2002
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. D., et al. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996–10015.
Price, J. L., and Drevets, W. C. (2010). Neurocircuitry of mood disorders. Neuropsychopharmacology 35, 192–216. doi: 10.1038/npp.2009.104
Prüss, H., Derst, C., Lommel, R., and Veh, R. W. (2005). Differential distribution of individual subunits of strongly inwardly rectifying potassium channels (Kir2 family) in rat brain. Brain Res. Mol. Brain Res. 139, 63–79. doi: 10.1016/j.molbrainres.2005.05.006
Rajasekaran, K., Sun, C., and Bertram, E. H. (2009). Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy. Neurobiol. Dis. 33, 119–132. doi: 10.1016/j.nbd.2008.09.023
Reppert, S. M., and Weaver, D. R. (2001). Molecular analysis of mammalian circadian rhythms. Annu. Rev. Physiol. 63, 647–676. doi: 10.1146/annurev.physiol.63.1.647
Richter, T. A., Kolaj, M., and Renaud, L. P. (2005). Low voltage-activated Ca2+ channels are coupled to Ca2+-induced Ca2+ release in rat thalamic midline neurons. J. Neurosci. 25, 8267–8271. doi: 10.1523/jneurosci.1942-05.2005
Richter, T. A., Kolaj, M., and Renaud, L. P. (2006). Heterogeneity in low voltage-activated Ca2+ channel-evoked Ca2+ responses within neurons of the thalamic paraventricular nucleus. Eur. J. Neurosci. 24, 1316–1324. doi: 10.1111/j.1460-9568.2006.05004.x
Rieck, R. W., Ansari, M. S., Whetsell, W. O. Jr., Deutch, A. Y., and Kessler, R. M. (2004). Distribution of dopamine D2-like receptors in the human thalamus: autoradiographic and PET studies. Neuropsychopharmacology 29, 362–372. doi: 10.1038/sj.npp.1300336
Rigby, M., O’Donnell, R., and Rupniak, N. M. (2005). Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain. J. Comp. Neurol. 490, 335–353. doi: 10.1002/cne.20664
Roberts, J. C., Davis, J. B., and Benham, C. D. (2004). [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res. 995, 176–183. doi: 10.1016/j.brainres.2003.10.001
Roesler, R., and Schwartsmann, G. (2012). Gastrin-releasing peptide receptors in the central nervous system: role in brain function and as a drug target. Front. Endocrinol. (Lausanne) 3:159. doi: 10.3389/fendo.2012.00159
Saenz del Burgo, L., Cortes, R., Mengod, G., Zarate, J., Echevarria, E., and Salles, J. (2008). Distribution and neurochemical characterization of neurons expressing GIRK channels in the rat brain. J. Comp. Neurol. 510, 581–606. doi: 10.1002/cne.21810
Saito, Y., Cheng, M., Leslie, F. M., and Civelli, O. (2001). Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J. Comp. Neurol. 435, 26–40. doi: 10.1002/cne.1191
Sakamoto, H., Matsuda, K. I., Zuloaga, D. G., Hongu, H., Wada, E., Jordan, C. L., et al. (2008). Sexually dimorphic gastrin releasing peptide system in the spinal cord controls male reproductive functions. Nat. Neurosci. 11, 634–636. doi: 10.1038/nn.2126
Sakurai, T., Amemiya, A., Ishi, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., et al. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585. doi: 10.1016/s0092-8674(00)80949-6
Salt, S. A., and Eaton, S. A. (1996). Functions of ionotropic and metabotropic glutamate receptors in sensory transmission in the mammalian thalamus. Prog. Neurobiol. 48, 55–72. doi: 10.1016/0301-0082(95)00047-x
Schöne, C., and Burdakov, D. (2012). Glutamate and GABA as rapid effectors of hypothalamic “peptidergic” neurons. Front. Behav. Neurosci. 6:81. doi: 10.3389/fnbeh.2012.00081
Schöne, C., Cao, Z. F. H., Apergis-Schoute, J., Adamantidis, A., Sakurai, T., and Burdakov, D. (2012). Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J. Neurosci. 32, 12437–12443. doi: 10.1523/JNEUROSCI.0706-12.2012
Scott, M. M., Lachey, J. L., Sternson, S. M., Lee, C. E., Elias, C. F., Friedman, J. M., et al. (2009). Leptin targets in the mouse brain. J. Comp. Neurol. 514, 518–532. doi: 10.1002/cne.22025
Sewards, T. V., and Sewards, M. A. (2003). Representations of motivational drives in mesial cortex, medial thalamus, hypothalamus and midbrain. Brain Res. Bull. 61, 25–49. doi: 10.1016/s0361-9230(03)00069-8
Shah, M. M., Javadzadeh-Tabatabaie, M., Benton, D. C., Ganellin, C. R., and Haylett, D. G. (2006). Enhancement of hippocampal pyramidal cell excitability by the novel selective slow-afterhyperpolarization channel blocker 3-(triphenylmethyl-aminomethyl) pyridine (UCL2077). Mol. Pharmacol. 70, 1494–1502. doi: 10.1124/mol.106.026625
Shekhtman, E., Geerling, J. C., and Loewy, A. D. (2007). Aldosterone-sensitive neurons of the nucleus of the solitary tract: multisynaptic pathway to the nucleus accumbens. J. Comp. Neurol. 501, 274–289. doi: 10.1002/cne.21245
Sofroniew, M. V., and Weindl, A. (1978). Projections from the parvocellular vasopressin- and neurophysin-containing neurons of the suprachiasmatic nucleus. Am. J. Anat. 153, 391–429. doi: 10.1002/aja.1001530305
Stanfield, P. R., Nakajima, S., and Nakajima, Y. (2002). Constitutively active and G-protein coupled inward rectifier K+ channels: Kir2.0 and Kir3.0. Rev. Physiol. Biochem. Pharmacol. 145, 47–179. doi: 10.1007/bfb0116431
Stratford, T. R., and Wirtshafer, D. (2013). Injections of muscimol into the paraventricular thalamic nucleus, but not mediodorsal thalamic nuclei, induce feeding in rats. Brain Res. 1490, 128–133. doi: 10.1016/j.brainres.2012.10.043
Su, H., and Bentivoglio, M. (1990). Thalamic midline cell populations projecting to the nucleus accumbens, amygdala and hippocampus in the rat. J. Comp. Neurol. 297, 582–593. doi: 10.1002/cne.902970410
Sun, Y., Lu, X., and Gershengorn, M. C. (2003). Thyrotropin-releasing hormone receptors–similarities and differences. J. Mol. Endocrinol. 30, 87–97. doi: 10.1677/jme.0.0300087
Sun, Y. G., and Chen, Z. F. (2007). A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448, 700–703. doi: 10.1038/nature06029
Swanson, C. J., Bures, M., Johnson, M. P., Linden, A. M., Monn, J. A., and Schoepp, D. D. (2005). Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat. Rev. Drug Discov. 4, 131–144. doi: 10.1038/nrd1630
Swanson, L. W., and Hartman, B. K. (1975). The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-β-hydroxylase as a marker. J. Comp. Neurol. 163, 467–506. doi: 10.1002/cne.901630406
Talley, E. M., Cribbs, L. L., Lee, J. H., Daud, A., Perez-Reyes, E., and Bayliss, D. A. (1999). Differential distribution of three members of a gene family encoding low voltage-activated (T type) calcium channels. J. Neurosci. 19, 1895–1911.
Talley, E. M., Solorzano, G., Lei, Q., Kim, D., and Bayliss, D. A. (2001). CNS distribution of members of the two-pore-domain (KCNK) potassium channel family. J. Neurosci. 21, 7491–7505.
Thomzig, A., Laube, G., Prüsse, H., and Veh, R. W. (2005). Pore-forming subunits of K-ATP channels, Kir6.1 and Kir6.2, display prominent differences in regional and cellular distribution in the rat brain. J. Comp. Neurol. 484, 313–330. doi: 10.1002/cne.20469
Torrealba, F., Yanagisawa, M., and Saper, C. B. (2003). Colocalization of orexin A and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 119, 1033–1044. doi: 10.1016/s0306-4522(03)00238-0
Torrecilla, M., Marker, C. L., Cintora, S. C., Stoffel, M., Williams, J. T., and Wickman, K. (2002). G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus coeruleus neurons. J. Neurosci. 22, 4328–4334.
van den Pol, A. N., and Tsujimoto, K. L. (1985). Neurotransmitters of the hypothalamic suprachiasmatic nucleus: immunohistochemical analysis of 25 neuronal antigens. Neuroscience 15, 1049–1086. doi: 10.1016/0306-4522(85)90254-4
Van der Werf, Y., Witter, M. P., and Groenewegen, H. J. (2002). The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res. Brain Res. Rev. 39, 107–140. doi: 10.1016/s0165-0173(02)00181-9
Veale, E. L., Buswell, R., Clarke, C. E., and Mathie, A. (2007). Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandemide. Br. J. Pharmacol. 152, 778–786. doi: 10.1038/sj.bjp.0707436
Vertes, R. P., and Hoover, W. B. (2008). Projections of the paraventricular and paratenial nuclei of the dorsal midline thalamus in the rat. J. Comp. Neurol. 508, 212–237. doi: 10.1002/cne.21679
Vogalis, F., Storm, J. F., and Lancaster, B. (2003). SK channels and the varieties of slow after-hyperpolarizations in neurons. Eur. J. Neurosci. 18, 3155–3166. doi: 10.1111/j.1460-9568.2003.03040.x
Wada, E., Wray, S., Key, S., and Battey, J. (1992). Comparison of gene expression for two distinct bombesin receptor subtypes in postnatal rat central nervous system. Mol. Cell. Neurosci. 3, 446–460. doi: 10.1016/1044-7431(92)90056-8
Watts, A. G., and Swanson, L. W. (1987). Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat. J. Comp. Neurol. 258, 230–252. doi: 10.1002/cne.902580205
Witkowski, G., Szulczyk, B., Rola, R., and Szulczyk, P. (2008). D (1) dopaminergic control of G protein-dependent inward rectifier K+ (GIRK)-like channel current in pyramidal neurons of the medial prefrontal cortex. Neuroscience 155, 53–63. doi: 10.1016/j.neuroscience.2008.05.021
Wittmann, G., Füzesi, T., Singru, P. S., Liposits, Z., and Lechan, R. M. (2009). Efferent projections of thyrotropin-releasing hormone-synthesizing neurons residing in the anterior subdivision of the hypothalamic paraventricular nucleus. J. Comp. Neurol. 515, 313–330. doi: 10.1002/cne.22017
Wittmann, G., Hrabovszky, E., and Lechan, R. M. (2013). Distinct glutamatergic and GABAergic subsets of hypothalamic pro-opiomelanocortin neurons revealed by in situ hybridization in male rats and mice. J. Comp. Neurol. 521, 3287–3302. doi: 10.1002/cne.23350
Wong, A. Y. C., Borduas, J.-F., Clarke, S., Lee, K. F. H., Béique, J.-C., and Bergeron, R. (2013). Calcium influx through N-type channels and activation of SK and TRP-like channels regulates tonic firing of neurons in rat paraventricular thalamus. J. Neurophysiol. 110, 2450–2464. doi: 10.1152/jn.00363.2013
Xu, Y. L., Gall, C. M., Jackson, V. R., Civelli, O., and Reinscheid, R. K. (2007). Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J. Comp. Neurol. 500, 84–102. doi: 10.1002/cne.21159
Xu, T.-R., Yang, Y., Ward, R., Gao, L., and Liu, Y. (2013). Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cell. Signal. 25, 2413–2423. doi: 10.1016/j.cellsig.2013.07.025
Yarbrough, G. G., Kamath, J., Winokur, A., and Prange, A. J. Jr. (2007). Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions. Med. Hypotheses 69, 1249–1256. doi: 10.1016/j.mehy.2007.04.005
Yoshimura, R., Kiyama, H., Kimura, T., Araki, T., Maeno, H., Tanizawa, O., et al. (1993). Localization of oxytocin receptor messenger ribonucleic acid in the rat brain. Endocrinology 133, 1239–1246. doi: 10.1210/en.133.3.1239
Zarbin, M. A., Kuhar, M. J., O’Donohue, T. L., Wolf, S. S., and Moody, T. W. (1985). Autoradiographic localization of (125I-Tyr4) bombesin-binding sites in rat brain. J. Neurosci. 5, 429–437.
Zhang, L., Doroshenko, P., Cao, X. Y., Irfan, N., Coderre, E., Kolaj, M., et al. (2006a). Vasopressin induces depolarization and state-dependent firing patterns in rat thalamic paraventricular nucleus in vitro. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R1226–R1232. doi: 10.1152/ajpregu.00770.2005
Zhang, L., Kolaj, M., and Renaud, L. P. (2006b). Suprachiasmatic nucleus communicates with anterior thalamic paraventricular nucleus neurons via rapid glutamatergic and gabaergic neurotransmission: state-dependent response patterns observed in vitro. Neuroscience 141, 2059–2066. doi: 10.1016/j.neuroscience.2006.05.042
Zhang, L., Kolaj, M., and Renaud, L. P. (2010). Ca2+- dependent and Na+- dependent K+ conductances contribute to a slow AHP in thalamic paraventricular nucleus neurons: a novel target for orexin receptors. J. Neurophysiol. 104, 2052–2062. doi: 10.1152/jn.00320.2010
Zhang, L., Kolaj, M., and Renaud, L. P. (2013). GIRK-like and TRPC-like conductances mediate thyrotropin-releasing hormone-induced increases in excitability in thalamic paraventricular nucleus neurons. Neuropharmacology 72, 106–115. doi: 10.1016/j.neuropharm.2013.04.023
Zhang, L., Renaud, L. P., and Kolaj, M. (2009). Properties of a T-type Ca2+ channel-activated slow afterhyperpolarization in thalamic paraventricular nucleus and other thalamic midline neurons. J. Neurophysiol. 101, 2741–2750. doi: 10.1152/jn.91183.2008
Ziegler, D. R., Cullinan, W. E., and Herman, J. P. (2002). Distribution of vesicular glutamate transporter mRNA in rat hypothalamus. J. Comp. Neurol. 448, 217–229. doi: 10.1002/cne.10257
Keywords: midline thalamic nuclei, electrophysiology, peptides, diurnal and seasonal changes, burst firing
Citation: Kolaj M, Zhang L, Hermes MLHJ and Renaud LP (2014) Intrinsic properties and neuropharmacology of midline paraventricular thalamic nucleus neurons. Front. Behav. Neurosci. 8:132. doi: 10.3389/fnbeh.2014.00132
Received: 26 January 2014; Accepted: 01 April 2014;
Published online: 17 April 2014.
Edited by:Christopher V. Dayas, University of Newcastle, Australia
Reviewed by:Matthew Philip Parsons, University of British Columbia, Canada
Jaclyn I. Wamsteeker Cusulin, University of Calgary, Canada
Copyright © 2014 Kolaj, Zhang, Hermes and Renaud. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Leo P. Renaud, Neuroscience Program and Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, 725 Parkdale Ave., Ottawa, ON K1Y 4E9, Canada e-mail: email@example.com